Contract 75A50124C00048
Nytricx, Inc. · Department Of Health And Human Services · September 13, 2024
Nytricx, Inc. was awarded a federal contract by Department Of Health And Human Services (Office Of Assistant Secretary For Preparedness And Response) on September 13, 2024 for $746,000 of work in research and development in biotechnology (except nanobiotechnology). Performance is in Athens, GA. It was awarded under full and open competition. The contract has been modified 1 time since the base award It uses firm fixed-price contract pricing. The most recent modification was on September 12, 2025.
Contract details
- PIID
- 75A50124C00048
- Award type
- Definitive Contract
- Pricing
- Firm Fixed Price
- Set-aside
- No Set Aside Used.
- Competition
- Full And Open Competition
- NAICS
- 541714 · Research And Development In Biotechnology (Except Nanobiotechnology)
- Product / service
- Health R&D Services; Health Care Services; Expenses For R&D Facilities And Major Equipment
- Place of performance
- Athens, GA
- First action
- September 13, 2024
- Latest action
- September 12, 2025
Description
NYTRICX, INC. R&D FOR PREVENTION OF ECMO CIRCUIT THROMBOSIS AND INFECTION BY SURFACE RELEASE OF NITRIC OXIDE (NO) AOI #19
Modification timeline
-
September 12, 2025Mod P00003 · Other Administrative Action$746.0K
-
September 13, 2024Base award$746.0K
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Vericel Corporation | Department Of Health And Human Services | April 1, 2026 | $34.88M |
| American College Of Medical Toxicology, Inc. | Department Of Health And Human Services | March 31, 2026 | $0 |
| Ceramedix Holding, Llc | Department Of Health And Human Services | March 31, 2026 | $4.22M |
| Glaxosmithkline, Llc | Department Of Health And Human Services | March 31, 2026 | $7.79M |
| Care Access Research Llc | Department Of Health And Human Services | March 31, 2026 | $2.55M |
| Pattern Bioscience, Inc. | Department Of Health And Human Services | March 31, 2026 | $22.50M |
Top contractors in NAICS 541714
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Amgen USA Inc | 1 | $59.99M |
| 2 | Vericel Corporation | 1 | $34.88M |
| 3 | Spectral Md, Inc. | 1 | $31.67M |
| 4 | Ppd Development Lp | 6 | $31.12M |
| 5 | L3 Technologies, Inc. | 1 | $22.00M |
| 6 | Technical Resources International, Inc. | 6 | $21.80M |
| 7 | Abbott Laboratories | 1 | $21.01M |
| 8 | Paratek Pharmaceuticals, Inc | 1 | $17.47M |
| 9 | Ossium Health, Inc. | 1 | $12.39M |
| 10 | Rho Federal Systems Division Inc | 1 | $8.00M |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract 75A50124C00048?
Contract 75A50124C00048 is a federal contract awarded to Nytricx, Inc. by Department Of Health And Human Services on September 13, 2024 for $746,000 of work classified under RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY). It has been modified 1 time since the base award.
Who won contract 75A50124C00048?
Nytricx, Inc. won contract 75A50124C00048 from Department Of Health And Human Services.
How much is contract 75A50124C00048 worth?
Contract 75A50124C00048 has obligated $746,000 to date.